AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33586478 — intervention group
Group type: COMPARATOR
Intervention: No VTE
Number of subjects: 7036
Study 32160420 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 1767
Study 35436976 — intervention group
Group type: EXPERIMENTAL
Intervention: Family systemic psychosocial support intervention
Number of subjects: 0
Study 35436976 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 34477330 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate (480 mg/day)
Number of subjects: 107
Study 34477330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 32292492 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 76
Study 32292492 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytosorb
Number of subjects: 76
Study 32292492 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 76
Study 36122646 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxia (FiO2 1.0)
Number of subjects: 20
Study 36122646 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia (FiO2 ≈ 0.11)
Number of subjects: 20
Study 36122646 — intervention group
Group type: COMPARATOR
Intervention: Baseline (room air)
Number of subjects: 20
Study 35450801 — intervention group
Group type: EXPERIMENTAL
Intervention: High omega-3LC group
Number of subjects: 46
Study 35450801 — intervention group
Group type: COMPARATOR
Intervention: Low omega-3LC group
Number of subjects: 46
Study 33067169 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 800 mg
Number of subjects: 168
Study 33067169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 35807801 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic treatment (Lactobacillus acidophilus LA‐5, Lactiplantibacillus plantarum UBLP‐40, Bifidobacterium animalis subsp. lactis BB‐12, Saccharomycesboulardii Unique‐28)
Number of subjects: 103
Study 35807801 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 32340871 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual-dose aspirin (325 mg)
Number of subjects: 321
Study 32340871 — intervention group
Group type: COMPARATOR
Intervention: Low-dose aspirin (81 mg)
Number of subjects: 321
Study 34273468 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme weekly locoregional hypofractionated radiation (HFRT)
Number of subjects: 50
Study 32307005 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin cessation strategy
Number of subjects: 2430
Study 32307005 — intervention group
Group type: COMPARATOR
Intervention: Continuing statin treatment at usual dosage
Number of subjects: 2430
Study 34733238 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist pretreatment
Number of subjects: 133
Study 34733238 — intervention group
Group type: COMPARATOR
Intervention: Control (no GnRH agonist pretreatment)
Number of subjects: 133
Study 33022417 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT (Photodithazine, 200 mg/L, 6 sessions, 3 times a week for 15 days)
Number of subjects: 65
Study 33022417 — intervention group
Group type: COMPARATOR
Intervention: NYS (nystatin, 1 dropper, 4 times a day for 15 days)
Number of subjects: 65
Study 33022417 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT
Number of subjects: 65
Study 33022417 — intervention group
Group type: COMPARATOR
Intervention: NYS
Number of subjects: 65
Study 36858761 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice group (n = 77) - participants could choose one of the two digital programs
Number of subjects: 155
Study 36858761 — intervention group
Group type: COMPARATOR
Intervention: No-choice group (n = 78) - participants assigned a program at random
Number of subjects: 155
Study 33570770 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak CK within 1st tertile (CK ≤259 U/L; n=1127 patients)
Number of subjects: 3368
Study 33570770 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak CK within 2nd tertile (CK 260 to 990 U/L; n=1119 patients)
Number of subjects: 3368
Study 33570770 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak CK within 3rd tertile (CK ≥991 U/L; n=1122 patients)
Number of subjects: 3368
Study 33570770 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak CK activity (adjusted)
Number of subjects: 3368
Study 32453306 — intervention group
Group type: EXPERIMENTAL
Intervention: LCPT 2 mg (morning dosing)
Number of subjects: 2
Study 32453306 — intervention group
Group type: COMPARATOR
Intervention: LCPT 2 mg (evening dosing)
Number of subjects: 2
Study 32453306 — intervention group
Group type: EXPERIMENTAL
Intervention: LCPT 5 mg (after high-calorie meal)
Number of subjects: 2
Study 32453306 — intervention group
Group type: COMPARATOR
Intervention: LCPT (fasted state)
Number of subjects: 2
Study 33579715 — intervention group
Group type: EXPERIMENTAL
Intervention: MiniMed Advanced Hybrid Closed-Loop (AHCL) system
Number of subjects: 60
Study 33579715 — intervention group
Group type: COMPARATOR
Intervention: Sensor-augmented pump therapy with predictive low glucose management (SAP + PLGM)
Number of subjects: 60
Study 32916125 — intervention group
Group type: EXPERIMENTAL
Intervention: Epigenomic reprogramming
Number of subjects: 0
Study 32916125 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromatin modifiers mutations
Number of subjects: 0
Study 36307098 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting plus 2 min of moderate-intensity activity every 30 min (INT)
Number of subjects: 14
Study 36307098 — intervention group
Group type: COMPARATOR
Intervention: Uninterrupted sitting (SIT)
Number of subjects: 14
Study 32468396 — intervention group
Group type: EXPERIMENTAL
Intervention: STEPS (Stepped Transition in Education Program for Students with ASD)
Number of subjects: 32
Study 32468396 — intervention group
Group type: COMPARATOR
Intervention: Transition as usual (TAU; waitlist control group)
Number of subjects: 32
Study 616886745 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention combined with routine nursing care
Number of subjects: 98
Study 616886745 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine nursing care only)
Number of subjects: 98
Study 36331698 — intervention group
Group type: EXPERIMENTAL
Intervention: Dads Matter-HV intervention
Number of subjects: 204
Study 36331698 — intervention group
Group type: COMPARATOR
Intervention: Standard home visiting services as usual (Control)
Number of subjects: 204
Study 33656380 — intervention group
Group type: EXPERIMENTAL
Intervention: Training targeting working memory (WM)
Number of subjects: 160
Study 33656380 — intervention group
Group type: EXPERIMENTAL
Intervention: Training targeting inhibitory control (IC)
Number of subjects: 160
Study 33656380 — intervention group
Group type: EXPERIMENTAL
Intervention: Training targeting cognitive flexibility (CF)
Number of subjects: 160
Study 33656380 — intervention group
Group type: COMPARATOR
Intervention: Active control group (comparatively engaging and challenging, but did not train a specific EF)
Number of subjects: 160
Study 32317724 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-molecule real-time sequencing technology
Number of subjects: 0
Study 33064065 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 32
Study 33064065 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 32
Study 33064065 — intervention group
Group type: COMPARATOR
Intervention: Control (HIIT)
Number of subjects: 32
Study 34073024 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine injection three times weekly
Number of subjects: 59
Study 34073024 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine injection once weekly
Number of subjects: 59
Study 34073024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 33337664 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosphenytoin, levetiracetam, or valproate (specific intervention not detailed in the abstract)
Number of subjects: 475
Study 33337664 — intervention group
Group type: COMPARATOR
Intervention: N/A (control group not specified)
Number of subjects: 475
Study 33574495 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation Laryngeal Mask Airway (LMA)
Number of subjects: 88
Study 33574495 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal Tube (ETT)
Number of subjects: 88
Study 33574495 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LMA and ETT
Number of subjects: 88
Study 32470492 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 0
Study 35883034 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-Centered Empowerment Model (FCEM) provided in four online sessions via WhatsApp messenger for two weeks after patient discharge.
Number of subjects: 70
Study 35883034 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 70
Study 34510703 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt meter plus dietary education (group A)
Number of subjects: 90
Study 34510703 — intervention group
Group type: COMPARATOR
Intervention: Education only (group B)
Number of subjects: 90
Study 32486525 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC‐TPL
Number of subjects: 41
Study 32486525 — intervention group
Group type: EXPERIMENTAL
Intervention: SAT
Number of subjects: 41
Study 32486525 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SAT depots
Number of subjects: 41
Study 36124697 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine-boosted
Number of subjects: 1062
Study 36124697 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinated with primary series only
Number of subjects: 1062
Study 36124697 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated
Number of subjects: 1062
Study 35177320 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational Animation Group (n = 44)
Number of subjects: 132
Study 35177320 — intervention group
Group type: COMPARATOR
Intervention: Documentary Group (n = 44)
Number of subjects: 132
Study 35177320 — intervention group
Group type: COMPARATOR
Intervention: Control Group (n = 44)
Number of subjects: 132
Study 34140345 — intervention group
Group type: EXPERIMENTAL
Intervention: 2+1 PCV13 schedule
Number of subjects: 20
Study 34140345 — intervention group
Group type: COMPARATOR
Intervention: 3+0 PCV13 schedule
Number of subjects: 20
Study 32291187 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous axial flow pumps
Number of subjects: 0
Study 32291187 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 35552078 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive heating (HT)
Number of subjects: 4
Study 35552078 — intervention group
Group type: COMPARATOR
Intervention: Thermoneutral control (TN)
Number of subjects: 4
Study 34219190 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hypertonic saline (HTS) to achieve and maintain plasma sodium between 145 and 150 mmol/l for 7 days
Number of subjects: 40
Study 34219190 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 40
Study 34219190 — intervention group
Group type: EXPERIMENTAL
Intervention: HTS group
Number of subjects: 40
Study 34365060 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste with Polish propolis, tea tree oil, menthol, and rosemary oil
Number of subjects: 50
Study 34365060 — intervention group
Group type: COMPARATOR
Intervention: Placebo toothpaste without active ingredients
Number of subjects: 50
Study 32671684 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol 5/5 µg
Number of subjects: 1078
Study 32671684 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium 5 µg
Number of subjects: 1078
Study 35705981 — intervention group
Group type: EXPERIMENTAL
Intervention: Anopheles gambiae
Number of subjects: 15632
Study 35705981 — intervention group
Group type: EXPERIMENTAL
Intervention: Anopheles funestus
Number of subjects: 15632
Study 35705981 — intervention group
Group type: EXPERIMENTAL
Intervention: EIR for both species
Number of subjects: 15632
Study 35705981 — intervention group
Group type: EXPERIMENTAL
Intervention: Anopheles coluzzii
Number of subjects: 15632
Study 33707305 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors (SGLT2is)
Number of subjects: 3
Study 33707305 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonists (GLP-1RAs)
Number of subjects: 3
Study 35706448 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk estimates (experimental group)
Number of subjects: 1363
Study 35706448 — intervention group
Group type: COMPARATOR
Intervention: Traditional risk factors (control group)
Number of subjects: 1363
Study 34427481 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive BP-lowering (systolic BP < 140 mmHg)
Number of subjects: 668
Study 34427481 — intervention group
Group type: COMPARATOR
Intervention: Conventional BP-lowering (systolic BP 140-180 mmHg)
Number of subjects: 668
Study 32084280 — intervention group
Group type: EXPERIMENTAL
Intervention: YAG vitreolysis treatment
Number of subjects: 35
Study 35266281 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (ABO) 50 U
Number of subjects: 399
Study 35266281 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (ABO) 75 U
Number of subjects: 399
Study 35266281 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (ABO) 100 U
Number of subjects: 399
Study 35266281 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (ABO) 125 U
Number of subjects: 399
Study 35266281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study 33245125 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning labels on SSB dispensers at the intervention site
Number of subjects: 840
Study 35793948 — intervention group
Group type: EXPERIMENTAL
Intervention: Overminus lens therapy
Number of subjects: 84
Study 35793948 — intervention group
Group type: COMPARATOR
Intervention: Control group (no overminus lens therapy)
Number of subjects: 84
Study 32635829 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure
Number of subjects: 12
Study 32591562 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide (PEA) 600 mg, one tablet a day
Number of subjects: 40
Study 36085270 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 2849
Study 36085270 — intervention group
Group type: COMPARATOR
Intervention: HRT cycle
Number of subjects: 2849
Study 36085270 — intervention group
Group type: COMPARATOR
Intervention: Natural cycle
Number of subjects: 2849
Study 35352176 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-TOX (fractionated docetaxel, oxaliplatin, capecitabine)
Number of subjects: 169
Study 35352176 — intervention group
Group type: COMPARATOR
Intervention: EOX (epirubicin, oxaliplatin, capecitabine)
Number of subjects: 169
Study 35352176 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-TOX
Number of subjects: 169
Study 35352176 — intervention group
Group type: COMPARATOR
Intervention: EOX
Number of subjects: 169
Study 34590247 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+ with added neck exercises (5 weeks, 3 times per week)
Number of subjects: 52
Study 34590247 — intervention group
Group type: COMPARATOR
Intervention: Usual part 2 of the FIFA 11+ (no neck exercises)
Number of subjects: 52
Study 34590247 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+ with added neck exercises
Number of subjects: 52
Study 32605614 — intervention group
Group type: EXPERIMENTAL
Intervention: stimuli-relevant AATP + treatment as usual (TAU)
Number of subjects: 204
Study 32605614 — intervention group
Group type: EXPERIMENTAL
Intervention: stimuli-relevant AATP in virtual reality + TAU
Number of subjects: 204
Study 32605614 — intervention group
Group type: COMPARATOR
Intervention: TAU only (control group)
Number of subjects: 204
Study 35503089 — intervention group
Group type: EXPERIMENTAL
Intervention: Equitable sociocultural classroom interactions
Number of subjects: 105
Study 35503089 — intervention group
Group type: EXPERIMENTAL
Intervention: Equitable disciplinary and personalized learning practices
Number of subjects: 105
Study 33909188 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus NCDC15 fermented milk with 8 g of Cichorium intybus root powder (LAC) along with basal diet
Number of subjects: 24
Study 33909188 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri BFE7 fermented milk with 8 g of Cichorium intybus root powder (LRC) along with basal diet
Number of subjects: 24
Study 33909188 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) provided with a basal diet alone
Number of subjects: 24
Study 35461831 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept or bevacizumab
Number of subjects: 330
Study 33764198 — intervention group
Group type: EXPERIMENTAL
Intervention: Inorganic nitrate therapy (12 mmol KNO3 capsules)
Number of subjects: 640
Study 33764198 — intervention group
Group type: COMPARATOR
Intervention: Placebo (potassium chloride capsules)
Number of subjects: 640
Study 36241455 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-PDN tool adapted to the French-Canadian context
Number of subjects: 0
Study 32008990 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic Kinesio Taping technique (technique A)
Number of subjects: 60
Study 32008990 — intervention group
Group type: EXPERIMENTAL
Intervention: New Kinesio Taping technique (technique B)
Number of subjects: 60
Study 32008990 — intervention group
Group type: COMPARATOR
Intervention: No Kinesio Taping (No-KT)
Number of subjects: 60
Study 34412699 — intervention group
Group type: EXPERIMENTAL
Intervention: Active educational intervention (12 hours of EBP-structured presentation)
Number of subjects: 69
Study 34412699 — intervention group
Group type: COMPARATOR
Intervention: Passive educational intervention (daily rounds, journal clubs, morning reports)
Number of subjects: 69
Study 32052995 — intervention group
Group type: COMPARATOR
Intervention: BWL (standard)
Number of subjects: 191
Study 32052995 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care
Number of subjects: 191
Study 32052995 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care with medication
Number of subjects: 191
Study 32052995 — intervention group
Group type: COMPARATOR
Intervention: Stepped care with placebo
Number of subjects: 191
Study 32052995 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care (range)
Number of subjects: 191
Study 35066899 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol (RSV) 1000 mg/day for 8 weeks
Number of subjects: 9
Study 35066899 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 9
Study 34031503 — intervention group
Group type: EXPERIMENTAL
Intervention: HDx with Theranova membrane
Number of subjects: 80
Study 34031503 — intervention group
Group type: COMPARATOR
Intervention: online-HDF
Number of subjects: 80
Study 34537386 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation Document (ID) for RoB2 tool
Number of subjects: 16
Study 34537386 — intervention group
Group type: COMPARATOR
Intervention: Calibration exercise before ID adoption
Number of subjects: 16
Study 34537386 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to apply RoB2 tool after ID adoption
Number of subjects: 16
Study 34537386 — intervention group
Group type: COMPARATOR
Intervention: Time to apply RoB2 tool before ID adoption
Number of subjects: 16
Study 34537386 — intervention group
Group type: COMPARATOR
Intervention: Calibration exercise and ID development time
Number of subjects: 16
Study 34033228 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured palliative care
Number of subjects: 68
Study 34033228 — intervention group
Group type: COMPARATOR
Intervention: Usual supportive care
Number of subjects: 68
Study 36316084 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGAD65
Number of subjects: 330
Study 36316084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study 33983755 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based relationship education programs
Number of subjects: 572
Study 33983755 — intervention group
Group type: COMPARATOR
Intervention: Matched sample (did not break up)
Number of subjects: 572
Study 32344842 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU/month for 6 months)
Number of subjects: 71
Study 32344842 — intervention group
Group type: COMPARATOR
Intervention: Placebo pearls (control group)
Number of subjects: 71
Study 36072363 — intervention group
Group type: EXPERIMENTAL
Intervention: Gardening sessions (hour-long, twice weekly for two months) with a group donating vegetables to a food pantry
Number of subjects: 10
Study 36072363 — intervention group
Group type: EXPERIMENTAL
Intervention: Gardening sessions (hour-long, twice weekly for two months) with a group harvesting produce for personal use
Number of subjects: 10
Study 34517135 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg methylprednisone
Number of subjects: 0
Study 34517135 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35674370 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based self-care program for 6 months
Number of subjects: 222
Study 35674370 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 222
Study 32520828 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (PRED) plus Azathioprine (AZA)
Number of subjects: 50
Study 32520828 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 50
Study 36132071 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning model based on enhanced MRI (T1)
Number of subjects: 120
Study 34460173 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanded Carrier Screening (ECS)
Number of subjects: 304
Study 34460173 — intervention group
Group type: COMPARATOR
Intervention: Usual care carrier screening
Number of subjects: 304
Study 32029306 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose prasugrel (30-mg load followed by 5 mg daily)
Number of subjects: 70
Study 32029306 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (600-mg load followed by 75 mg daily)
Number of subjects: 70
Study 33772375 — intervention group
Group type: EXPERIMENTAL
Intervention: DFVC angle of 4°
Number of subjects: 125
Study 33772375 — intervention group
Group type: EXPERIMENTAL
Intervention: DFVC angle of 5°
Number of subjects: 125
Study 33772375 — intervention group
Group type: EXPERIMENTAL
Intervention: DFVC angle of 6°
Number of subjects: 125
Study 32562057 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (onabotulinumtoxinA)
Number of subjects: 0